Stocksigma LogoStocksigma Logo

Nazara Approves Leadership Transition, Preferential Allotment, and Subsidiary Capital Infusions

On 12th Oct'26, Nazara Technologies approved key leadership changes: Founder Nitish Mittersain transitioned from MD to Non-Executive Director, Mithun

Nazara Approves Leadership Transition, Preferential Allotment, and Subsidiary Capital Infusions

Nazara Technologies Ltd · Change in Management · 12 Oct 2026, 11:58 pm

Nazara Approves Leadership Transition, Preferential Allotment, and Subsidiary Capital Infusions On 12th Oct'26, Nazara Technologies approved key leadership changes: Founder Nitish Mittersain transitioned from MD to Non-Executive Director, Mithun Sacheti was appointed Executive Director, and Arun Agrawal became CFO effective 16th Oct'26, succeeding Rakesh Shah. The board allotted 2.39 crore equity shares at ₹306 each (~₹730.78 crore) on a preferential basis. Additionally, it approved infusing up to $77 million (~₹742.72 crore) into Nazara UK and converting inter-corporate loans of ~₹129.35 crore in Smaaash and ~₹294.40 crore in Nazara UK into equity.

Original exchange filing (PDF)

More announcements from Nazara Technologies Ltd

All Nazara Technologies Ltd announcements